The Helminth Genomics team, led by Dr. Stephen Doyle, uses multidisciplinary approaches to understand genetic and phenotypic variation in parasitic worms that infect humans and animals. 

We generate and analyse population-wide to single-cell resolution genomic datasets to understand the genetic basis for parasitic worms' evolutionary success and future potential and to identify evolutionary constraints that may be exploited to control them.

Related Sanger Institute blog

Related Sanger Institute blog

Unravelling how parasitic worms respond to drug treatment

Read the blog article

The global burden of parasitic worm infections

Parasitic worms (known as helminths) are a group of organisms that exploit an incredibly diverse range of hosts and life history strategies so that they can persist across generations. Helminth infections of humans and animals of veterinary importance, such as companion and food-producing animals, are responsible for a significant disease burden in their hosts that causes pain, disability, developmental delay, and in some cases, death around the world.

Worldwide, more than 1.5 billion people and countless animals are infected with one or more helminth species at any given time. The importance of drugs to control helminth infections (known as anthelmintics) cannot be understated. Human helminth infections are the target of large-scale mass drug administration campaigns. In veterinary settings hundreds of millions of animals are treated with anthelmintic drugs to prevent and/or cure infections.

Our research

Genomics increasingly plays a critical role in understanding parasite worm biology. At the foundation of many wet and dry lab studies is the reference genome, which can provide great insights into the form and function of parasites and the evolutionary processes that make them successful.

Understanding parasite biology through genomics

Generating and openly sharing reference genomes

We have led and contributed to generating high-quality reference genomes for several parasitic worm species, supporting ongoing curation of genome annotations and resources that are shared openly for our work and the parasitology community. These resources are primarily shared via WormBase ParaSite an invaluable resource for helminth biology that we contribute to and make use of constantly.

Developing and analysing single-cell, spatial, and developmental timecourse datasets

We have led the generation of rich datasets to understand parasite biology, including developmental transcriptional timecourses and are currently working on single-nuclei RNAseq and spatial transcriptomic atlases to both better understand the developmental biology of these parasites and reveal greater knowledge of the expression characteristics of many genes of unknown function.

Analysing parasite response to drug treatment

A strong theme in the group is focused on understanding parasite responses to drug treatment.

We use natural host-parasite systems such as Haemonchus contortus in sheep and field isolates of parasites such as Teladorsagia circumcincta and Dirofilaria immitis collected from around the world to map genetic variation associated with drug resistance to the vital drug classes used to control parasitic worms.

In humans, we have contributed to the understanding of the genetics of praziquantel resistance in Schistosoma mansoni and are currently focused on understanding treatment response variation in large cohorts of soil-transmitted parasites collected as part of clinical trials to evaluate new approaches for control.

Laying the foundations for public health monitoring and intervention

The ability to accurately and sensitively diagnose parasite infections is at the forefront of efforts to control parasites as a public health problem and their elimination.

We have surveyed soil-transmitted helminth diversity to understand the impact of genetic variation on the success of molecular diagnostics and are currently developing scaleable and portable amplicon sequencing approaches to detect mixed parasite infections. We aim to use these tools to measure the impact of treatment approaches and interactions with other variables, such as environmental and health outcomes, on parasite community diversity.

Generating and openly sharing foundational resources

Collectively, we seek to build foundational knowledge of parasites that infect humans and animals and to use this knowledge to improve the control of parasites as a human and animal health burden worldwide.

Core team

Photo of Dr Sarah K Buddenborg

Dr Sarah K Buddenborg

Postdoctoral Fellow

Photo of Dr Javier Gandasegui

Dr Javier Gandasegui

Staff Scientist

Partners

We work with the following research collaborations and partners

External

BUG Consortium

Collaboration

External

STOP Consortium

Collaboration

External

Dave Bartley

Moredun Research Institute

Scientific collaborator

External

Matt Berriman

University of Glasgow

Scientific collaborator

External

Cinzia Cantacessi

University of Cambridge

Scientific collaborator

External

James Cotton

University of Glasgow

Scientific collaborator

External

Maria Duque-Correa

University of Cambridge

Scientific collaborator

External

Wendemagegn Embiale

Bahir Dar University, Ethiopia

Scientific collaborator

External

Warwick Grant

La Trobe University, Australia

Scientific collaborator

External

Vicky Hunt

University of Bath

Scientific collaborator

External

Roz Laing

University of Glasgow; BUG Consortium

Scientific collaborator

External

Anne Lespine

French National Institute for Agriculture, Food, and Environment (INRAE), France

Scientific collaborator

External

Tim Littlewood

Natural History Museum, London

Scientific collaborator

External

Inácio Mandomando

Centro de Investigação em Saúde de Manhiça (CISM), Mozambique

Scientific collaborator

External

Peter Nejsum

Aarhus University, Denmark

Scientific collaborator

External

Neil Sargison

University of Edinburgh

Scientific collaborator

External

Jan Slapeta

University of Sydney, Australia

Scientific collaborator

External

STOP2030 

Ghana Health Service, Kenya Medical Research Institute (KEMRI), Laboratorios Liconsa SA (Liconsa), Fundación Mundo Sano (FMS), The Barcelona Institute for Global Health, ISGlobal, Bridges To Development

Collaboration

External

Arporn (Koi) Wangwiwatsin

Khon Kaen University, Thailand

Scientific collaborator

External

Bonnie Webster

Natural History Museum

Scientific collaborator

External

Joanne Webster

Royal Veterinary College

Scientific collaborator

 

Publications

Loading publications...